News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,395 Results
Type
Article (14480)
Company Profile (86)
Press Release (263827)
Multimedia
Podcasts (71)
Webinars (14)
Section
Business (88401)
Career Advice (468)
Deals (15448)
Drug Delivery (83)
Drug Development (36782)
Employer Resources (50)
FDA (6417)
Job Trends (6248)
News (150945)
Policy (14145)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (455)
Accelerated approval (25)
ADA (10)
Adcomms (9)
Allergies (99)
Alliances (23323)
ALS (74)
Alzheimer's disease (526)
Antibody-drug conjugate (ADC) (167)
Approvals (6743)
Artificial intelligence (277)
ASCO (113)
Autoimmune disease (79)
Automation (22)
Bankruptcy (152)
Best Places to Work (4371)
BIO (21)
BIOSECURE Act (9)
Biosimilars (154)
Biotechnology (36)
Bladder cancer (51)
Brain cancer (41)
Breast cancer (212)
Cancer (1750)
Cardiovascular disease (202)
Career advice (422)
Career pathing (14)
CAR-T (67)
CDC (7)
Cell therapy (202)
Cervical cancer (20)
Clinical research (32652)
Collaboration (964)
Commercialization (1)
Company closure (1)
Compensation (415)
Complete response letters (47)
COVID-19 (786)
CRISPR (55)
C-suite (654)
Cystic fibrosis (62)
Data (2584)
Decentralized trials (1)
Denatured (19)
Depression (61)
Dermatology (16)
Diabetes (167)
Diagnostics (1459)
Digital health (17)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (168)
Drug pricing (122)
Drug shortages (15)
Duchenne muscular dystrophy (102)
Earnings (34252)
Editorial (24)
Employer branding (4)
Employer resources (46)
Events (39974)
Executive appointments (620)
FDA (7853)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (557)
Gene editing (87)
Generative AI (28)
Gene therapy (206)
GLP-1 (496)
Government (1433)
Grass and pollen (4)
Guidances (173)
Healthcare (3643)
Hematology (67)
HIV (18)
Huntington's disease (12)
IgA nephropathy (53)
Immunology and inflammation (85)
Immuno-oncology (30)
Indications (101)
Infectious disease (885)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (29)
Intellectual property (142)
Interviews (60)
IPO (5929)
IRA (33)
Job creations (2060)
Job search strategy (375)
JPM (29)
Kidney cancer (12)
Labor market (38)
Layoffs (211)
Leadership (10)
Legal (3451)
Liver cancer (26)
Longevity (10)
Lung cancer (237)
Lymphoma (163)
Machine learning (16)
Management (17)
Manufacturing (581)
Marketing (1)
MASH (91)
Medical affairs (1)
Medical device (1314)
Medtech (1331)
Mergers & acquisitions (10050)
Metabolic disorders (572)
mRNA (64)
Multiple sclerosis (60)
NASH (15)
Neurodegenerative disease (113)
Neuropsychiatric disorders (49)
Neuroscience (1071)
Neurotech (1)
NextGen: Class of 2026 (1591)
Non-profit (608)
Now hiring (24)
Obesity (294)
Opinion (152)
Ovarian cancer (66)
Pain (148)
Pancreatic cancer (73)
Parkinson's disease (112)
Partnered (12)
Patents (286)
Patient recruitment (189)
Peanut (15)
People (30281)
Pharmaceutical (48)
Pharmacy benefit managers (19)
Phase 1 (8457)
Phase 2 (13793)
Phase 3 (12456)
Pipeline (3596)
Policy (150)
Postmarket research (1404)
Preclinical (3410)
Press Release (25)
Prostate cancer (114)
Psychedelics (22)
Radiopharmaceuticals (162)
Rare diseases (483)
Real estate (2668)
Recruiting (19)
Regulatory (11444)
Reports (16)
Research institute (583)
Resumes & cover letters (56)
Rett syndrome (12)
RNA editing (9)
RSV (25)
Schizophrenia (87)
Series A (115)
Series B (66)
Service/supplier (2)
Sickle cell disease (57)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (11)
Startups (1652)
State (2)
Stomach cancer (6)
Supply chain (65)
Tariffs (71)
The Weekly (50)
Vaccines (276)
Venture capital (40)
Weight loss (173)
Women's health (50)
Worklife (4)
Date
Today (45)
Last 7 days (172)
Last 30 days (855)
Last 365 days (10385)
2026 (5480)
2025 (10745)
2024 (12504)
2023 (14255)
2022 (19566)
2021 (20073)
2020 (19034)
2019 (14884)
2018 (11713)
2017 (13888)
2016 (13130)
2015 (15472)
2014 (12420)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (323)
Alabama (20)
Alaska (1)
Arizona (88)
Arkansas (4)
Asia (21284)
Australia (2744)
California (4021)
Canada (1811)
China (761)
Colorado (176)
Connecticut (157)
Delaware (170)
Europe (41704)
Florida (766)
Georgia (76)
Hawaii (1)
Idaho (11)
Illinois (464)
India (69)
Indiana (311)
Iowa (2)
Japan (358)
Kansas (84)
Kentucky (21)
Louisiana (7)
Maine (2)
Maryland (504)
Massachusetts (3211)
Michigan (55)
Minnesota (208)
Mississippi (1)
Missouri (39)
Montana (9)
Nebraska (8)
Nevada (19)
New Hampshire (9)
New Jersey (1780)
New Mexico (7)
New York (1141)
North Carolina (747)
North Dakota (2)
Northern California (1926)
Ohio (94)
Oklahoma (5)
Oregon (18)
Pennsylvania (860)
Puerto Rico (18)
Rhode Island (18)
South America (508)
South Carolina (11)
Southern California (1751)
Tennessee (70)
Texas (565)
United States (15823)
Utah (66)
Vermont (1)
Virginia (212)
Washington D.C. (42)
Washington State (289)
West Virginia (1)
Wisconsin (51)
Wyoming (1)
278,395 Results for "pacira pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
May 26, 2026
·
13 min read
Press Releases
Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS’ Recommendation to Vote “FOR” All of Pacira’s Director Nominees
June 2, 2026
·
12 min read
Press Releases
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
May 29, 2026
·
12 min read
Press Releases
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
June 30, 2026
·
9 min read
Press Releases
Pacira BioSciences Announces Stockholders Have Elected All Three of the Company’s Director Nominees at Annual Meeting
June 10, 2026
·
6 min read
Press Releases
Pacira BioSciences Reports First Quarter 2026 Financial Results
April 30, 2026
·
30 min read
Press Releases
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
April 29, 2026
·
32 min read
Press Releases
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
May 13, 2026
·
17 min read
Press Releases
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
May 27, 2026
·
25 min read
Press Releases
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences - May 13, 2026
May 13, 2026
·
1 min read
1 of 27,840
Next
